Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new published version of the page content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check47 days agoChange DetectedThe location entry for Vienna was updated from 'Vienna, Vienna, Austria, 1140' to 'Vienna, State of Vienna, Austria, 1140', and the page revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded the disease term Small cell lung carcinoma and the Genetic and Rare Diseases Information Center as a resources entry.SummaryDifference0.1%

- Check75 days agoChange DetectedStudy protocol revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check89 days agoChange Detected- Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.